Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Current experimental
stroke
research has evolved to focus on detailed understanding of the brain's self-protective and restorative mechanisms, and harness this knowledge for development of new therapies. In this context, the role of peptidases and neuropeptides is of growing interest. In this focused review, peptidase neurolysin (Nln) and its extracellular peptide substrates are briefly discussed in relation to pathophysiology of ischemic
stroke
. Upregulation of Nln following
stroke
is viewed as a compensatory cerebroprotective mechanism in the acute phase of
stroke
, because the main neuropeptides inactivated by Nln are neuro/cerebrotoxic (bradykinin,
substance P
, neurotensin, angiotensin II, hemopressin), whereas the peptides generated by Nln are neuro/cerebroprotective (angiotensin-(1-7), Leu-/Met-enkephalins). This notion is confirmed by experimental studies documenting aggravation of
stroke
outcomes in mice after inhibition of Nln following
stroke
, and dramatic improvement of
stroke
outcomes in mice overexpressing Nln in the brain. The role of Nln in the (sub)chronic phase of
stroke
is less clear and it is likely, that this peptidase does not have a major role in neural repair mechanisms. This is because, the substrates of Nln are less uniform in modulating neurorestorative mechanisms in one direction, some appearing to have neural repair enhancing/stimulating potential, whereas others doing the opposite. Future studies focusing on the role of Nln in pathophysiology of
stroke
should determine its potential as a cerebroprotective target for
stroke
therapy, because its unique ability to modulate multiple neuropeptide systems critically involved in brain injury mechanisms is likely advantageous over modulation of one pathogenic pathway for
stroke
pharmacotherapy.
...
PMID:The role of peptidase neurolysin in neuroprotection and neural repair after stroke. 3278 43
Varicella and zoster, produced by varicella-zoster virus (VZV), are associated with an increased risk of
stroke
that may be due to persistent inflammation and hypercoagulability. Because
substance P
is associated with inflammation, hypercoagulability, and atherosclerotic plaque rupture that may contribute to increased
stroke
risk after VZV infection, we measured serum
substance P
in simian varicella virus-infected rhesus macaques. We found significantly increased and persistent serum
substance P
concentrations during varicella and zoster compared with pre-inoculation, supporting the hypothesis that VZV-induced increases in serum
substance P
may contribute to increased
stroke
risk associated with VZV infection.
...
PMID:Elevated serum substance P during simian varicella virus infection in rhesus macaques: implications for chronic inflammation and adverse cerebrovascular events. 3296 7
The descending motor nerve conduction of voluntary swallowing is mainly launched by primary motor cortex (M1). M1 can activate and regulate peripheral nerves (hypoglossal) to control the swallowing. Acupuncture at "Lianquan" acupoint (CV23) has a positive effect against poststroke dysphagia (PSD). In previous work, we have demonstrated that electroacupuncture (EA) could regulate swallowing-related motor neurons and promote swallowing activity in the essential part of central pattern generator (CPG), containing nucleus ambiguus (NA), nucleus of the solitary tract (NTS), and ventrolateral medulla (VLM) under the physiological condition. In the present work, we have investigated the effects of EA on the PSD mice
in vivo
and sought evidence for PSD improvement by electrophysiology recording and laser speckle contrast imaging (LSCI). Four main conclusions can be drawn from our study: (i) EA may enhance the local field potential in noninfarction area of M1, activate the swallowing-related neurons (pyramidal cells), and increase the motor conduction of noninfarction area in voluntary swallowing; (ii) EA may improve the blood flow in both M1 on the healthy side and deglutition muscles and relieve PSD symptoms; (iii) EA could increase the motor conduction velocity (MCV) in hypoglossal nerve, enhance the EMG of mylohyoid muscle, alleviate the paralysis of swallowing muscles, release the
substance P
, and restore the ability to drink water; and (iv) EA can boost the functional compensation of M1 in the noninfarction side, strengthen the excitatory of hypoglossal nerve, and be involved in the voluntary swallowing neural control to improve PSD. This research provides a timely and necessary experimental evidence of the motor neural regulation in dysphagia after
stroke
by acupuncture in clinic.
...
PMID:Electroacupuncture Involved in Motor Cortex and Hypoglossal Neural Control to Improve Voluntary Swallowing of Poststroke Dysphagia Mice. 3306 53
<< Previous
1
2
3
4
5
6
7
8